[Recent acquisitions in cancer chemotherapy].
作者信息
Amiel J L, Bernard J, Bessis M, Dreyfus B, Najean Y, Seligmann M, Péquignot H
出版信息
Presse Med (1893). 1966 Jun 25;74(32):1683-6.
PMID:5935822
Abstract
摘要
相似文献
1
[Recent acquisitions in cancer chemotherapy].[癌症化疗的近期进展]
Presse Med (1893). 1966 Jun 25;74(32):1683-6.
2
[Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].[关于一种近期与放疗联合使用的抗肿瘤药物（甲基肼）的观察]
Minerva Radiol. 1968 Sep;13(9):470-8.
3
[Segidrin: a new-type antineoplastic agent].
Vopr Onkol. 1994;40(1-3):3-14.
4
5
[Recent cytostatic therapy in hemoblastosis and malignant tumors].[血液系统恶性肿瘤和恶性肿瘤的近期细胞抑制疗法]
Wien Klin Wochenschr. 1966 Jul 1;78(26):487-8.
6
Pharmacologic aspects of the chemotherapy of solid tumors.实体肿瘤化疗的药理学方面
Pharmacol Physicians. 1968 Sep;2(9):1-6.
7
8
Supportive care drug studies: some promising, some not.支持性护理药物研究：有些前景光明，有些则不然。
Oncology (Williston Park). 1992 Sep;6(9):93-4.
9
[Drug therapy of cancer cachexia].
Ugeskr Laeger. 1994 Jan 10;156(2):203-6.
10
[Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].[甲基肼系列新型细胞抑制剂（丙卡巴肼）的使用经验。特别提及血液学副作用]
Schweiz Med Wochenschr. 1965 Sep 11;95(37):1233-40.
Zotero 插件